This move is archived. Current quotes and coverage live on the stock page.
Follow COV
Covalon Technologies Ltd. experienced a remarkable increase in its stock price, closing up nearly 28% in yesterday's trading session.
Covalon Technologies Ltd. saw its stock price soar by 27.95% yesterday, closing at CA$2.93. This surge reflects positive investor sentiment and confidence in the company's growth trajectory, particularly following its recent financial results.
Advertisement
Covalon Technologies Ltd.
COV.V
COV.V
Covalon Technologies Ltd.
WealthAwesomeMarket cap
$109.64M
P/E
24.8x
52W high
$4.59
52W low
$1.55
1W change
+2.84%
Beta
0.17
Analyst Price Targets
Based on analyst covering COV · as of Sep 17, 2026
Wall Street analysts forecast COV stock price to fall 27.3% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.90
-27.3% Upside
Current Price
C$3.99
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on COV's historical volatility
30-Day Vol
91.2%
Annualized
90-Day Vol
74.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.75
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.21 | C$3.08 – C$5.77 |
| 60 trading days | C$4.47 | C$2.87 – C$6.98 |
| 90 trading days | C$4.75 | C$2.75 – C$8.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of Covalon's strong quarterly performance and its focus on contamination prevention technologies, which could drive future growth.
Covalon Technologies Ltd. stock jumps 27.95% in one day
Advertisement
The market cap of Covalon reached CA$63.25 million following the surge, reflecting increased investor interest.
Bull case
Covalon's recent financial results show significant revenue and income growth, indicating strong operational performance. The company is focused on innovative medical technologies, which positions it well for future expansion.
Bear case
Even with the positive movement, investors should be cautious. Covalon's P/E ratio of 58.6 suggests it may be overvalued compared to its industry peers. Additionally, the lack of recent news could lead to volatility.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
